CCT a risk factor for glaucoma damage

Article

CCT a risk factor for glaucoma damage

Central corneal thickness (CCT) and corneal hysteresis could present a pressure-independent risk factor for glaucoma damage, according to a report in the May issue of the American Journal of Ophthalmology.

N.G. Congdon and colleagues from the John Hopkins University School of Medicine conducted an observational study of 230 patients undergoing measurements for hysteresis, on the Reichert Ocular Response Analyser, and CCT by ultrasonic pachymetry. Charts were reviewed to determine highest known intraocular pressure (IOP), target IOP, diagnosis, number of years with glaucoma, cup-to-disk ratio (CDR), mean defect, pattern standard deviation, glaucoma hemifield test and the presence or absence of visual field progression. Of the 230 patients (127 female, 103 male) 85% had a diagnosis of primary open-angle glaucoma (POAG) or suspected POAG.

The researchers found that lower corneal hysteresis values (p=0.03) were associated with visual field progression, but CCT was not. When axial length was included in the model, hysteresis was not a significant risk factor (p=0.09). Thinner CCT measurements were associated with a higher CDR but neither CCT nor hysteresis were linked with mean defect, pattern standard deviation or glaucoma hemifield test. Thinner CCT was associated with the state of glaucoma damage, as indicated by CDR, and axial length and corneal hysteresis were linked to progressive field worsening.

It was concluded that CCT and hysteresis may constitute a risk factor for glaucoma damage, related to the composition of the eye wall itself.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.